UCL top 10 in the world for medicine, life sciences, pharmacy and education
UCL has been placed 7th globally for medicine, 4th globally for pharmacy and pharmacology and 1st for education in the QS World University Rankings by Subject 2022.
BRC News
High blood pressure and its treatment not risk factors for worse Covid outcomes
High blood pressure and treatments to control it do not increase the risk of hospitalisation and death from Covid-19, according to a large European-wide study which in the UK was co-ordinated at UCLH and UCL.
Artificial intelligence can predict the impact of scientific discoveries in medicine
Technology could be used to identify published scientific papers that have the greatest potential for real world impact – such as new medical treatments – according to UCL and UCLH research.
New technology to improve cancer care to be tested in clinical practice
UCLH have been awarded a grant of over half a million pounds to test in clinical practice new technology designed to improve cancer care.
Researchers wanted to offer summer placements to disadvantaged students
The charity In2scienceUK is looking for researchers who can provide lab placements this summer for A-level students from disadvantaged backgrounds.
Major UCLH investment in research and training to benefit staff and patients
A UCLH investment of £20 million will fund training for healthcare assistants and major new research facilities which will benefit patient care.
UCLH to be part of vital health data partnership
UCLH is to work in partnership with University Hospitals Birmingham NHS Foundation Trust in a major digital health initiative in which researchers use data collected in acute care settings to improve patient care.
Researchers across England and Wales benefit from UCLH PPI training
Clinicians and research staff from across England and Wales attended patient and public involvement training delivered by the BRC between April 2021 and March 2022.
World-first CJD treatment shows promising early results
A world-first treatment for Creutzfeldt-Jakob disease (CJD) has shown “very encouraging” early results following its use in six patients at UCLH.
People without jobs or secure housing have worse outcomes when treated for depression
People without jobs or with less secure housing have poorer outcomes when treated for depression with talking therapy or antidepressants, compared to more socially advantaged peers, according to UCL led research.
20 second AI heart tool begins NHS roll-out
A new artificial intelligence (AI) tool that can detect heart disease in record speed, helping to improve care for heart patients, is being rolled out at UCLH.
Single test for over 50 genetic diseases to cut diagnosis from decades to days
A single DNA test has been developed that can screen a patient’s genome for over 50 genetic neurological and neuromuscular diseases such as Huntington’s disease, muscular dystrophies and fragile X syndrome.
Hard-hitting film on tackling obesity
Professor Rachel Batterham and the Royal College of Physicians have developed a documentary on the growing obesity crisis.
Can MRI scans predict MS progression?
Two UCL and UCLH studies will look at whether analysis of advanced MRI scans can predict onset of multiple sclerosis and indicate which MS patients are at risk of developing irreversible disability.
Clinical Research Facility at UCLH awarded £10 million
The Clinical Research Facility at UCLH has been awarded £10 million in funding to deliver cutting edge early phase health research in areas including cancer and dementia.
